Solvay posts Q2 adjusted EBITDA of €187m and upholds 2026 financial targets
Solvay reported adjusted EBITDA of €187 million for the second quarter, slightly under Jefferies' estimate but modestly ahead of consensus. Group sales declined to €1,031 million with organic sales down 7.4% driven by lower volumes and reduced pricing. The company reiterated its full-year 2026 guidance for EBITDA, free cash flow, and capital expend…